CellSource Co., Ltd. (TYO:4880)

Revenue by Segment

Financials in millions JPY. Fiscal year is November - October.

Fiscal Year	FY 2025
Period Ending	Oct 31, 2025
Regenerative Medicine-related Business	3.71B
Total	3.71B

Revenue by Geography

Financials in millions JPY. Fiscal year is November - October.

Fiscal Year	FY 2025
Period Ending	Oct 31, 2025
Japan	3.71B
Total	3.71B

Source: S&P Global Market Intelligence.